Systems And Methods For Using Photoplethysmography In The Administration Of Narcotic Reversal Agents
OwnerRichard J. Melker, Donn M. Dennisinventors
Life of this patent
Estimating the term…
Abstract
Provided according to embodiments of the present invention are methods of monitoring and treating respiratory depression that include securing a photoplethysmography (PPG) sensor to a central source site of an individual; administering a central nervous system (CNS) depressant to the individual; processing PPG signals front the PPG sensor with a computer in communication with the PPG sensor; and administering a narcotic reversal agent to the individual if the PPG signals or a physiological parameter derived therefrom are outside a preset value range. Related systems are also described.
Claims46
A method of monitoring and treating respiratory depression comprising:
- securing a photoplethysmography (PPG) sensor to a central source site of an individual;
- administering a central nervous system (CNS) depressant to the individual;
- processing PPG signals from the PPG sensor with a controller in communication with the PPG sensor;
- and
- administering a narcotic reversal agent to the individual if the PPG signals or a physiological parameter derived therefrom are outside a preset value range.
A system for monitoring and treating respiratory depression comprising:
- a PPG sensor configured to secure to a central source site of an individual;
- a device configured to administer a narcotic reversal agent to the individual;
- and
- a controller configured (1) to receive and process PPG signals from the PPG sensor, and (2) to direct the device to administer the narcotic reversal agent to the individual if the PPG signals or a physiological parameter derived therefrom are outside a preset value range.
Dependencies are inferred from the claim text.